Noninvasive Prenatal Diagnosis for Duchenne Muscular Dystrophy Based on the Direct Haplotype Phasing M Chen et al, BioxRIV preprints, July 31, 2019

Main|Search|PHGKB




Last Posted: Aug 02, 2019

---

• Noninvasive Prenatal Diagnosis for Duchenne Muscular Dystrophy Based on the Direct Haplotype Phasing
  M Chen et al, BioxRIV preprints, July 31, 2019
• Update in Duchenne and Becker muscular dystrophy.
  Waldrop Megan A et al. Current opinion in neurology 2019 Jul
• Is Molecular Diagnosis Necessary for Children with Duchenne Muscular Dystrophy?
  Puri Ratna Dua et al. Indian pediatrics 2019 Jul 56(7) 549-550
• Living with Muscular Dystrophy
  CDC, 2019
• De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany.
  König Kirsten et al. Orphanet journal of rare diseases 2019 Jun 14(1) 152
• New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges.
  Ricci Federica et al. Expert review of clinical pharmacology 2019 Jun
• Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing.
  Luo Sushan et al. BMC neurology 2019 May 19(1) 92
• Haplotype-Based noninvasive prenatal diagnosis for duchenne muscular dystrophy: A pilot study in South China.
  Chen Min et al. European journal of obstetrics, gynecology, and reproductive biology 2019 May 24015-22
• Reliability and validity of the Thai version of the Pediatric Quality of Life inventory? 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
  Thongsing Apirada et al. Health and quality of life outcomes 2019 May 17(1) 76
• Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps.
  Baker Mei et al. JAMA neurology 2019 May

more